Pivotal Life Sciences
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
- USA
- China
- Hong Kong
Investment stages
- Pre-Seed
- Seed
- Series A
- Series B
- Series C
Industries
- Health Tech
- Biotechnology
- AI
- Fintech
About
Pivotal Life Sciences is a leading venture capital firm dedicated to funding innovative companies that are pioneering therapeutic solutions for significant unmet medical needs. Established in 2017, we leverage our deep industry expertise to identify and support transformative therapeutic advancements that can improve patient outcomes. Our strategic investment approach focuses on fostering growth in the life sciences sector, ensuring that breakthrough therapies reach the market while enhancing the overall healthcare landscape. Through our commitment to innovation and excellence, Pivotal Life Sciences aims to be a catalyst for change in the medical field.
Pivotal Life Sciences is a leading venture capital firm dedicated to funding innovative companies that are pioneering therapeutic solutions for significant unmet medical needs. Established in 2017, we leverage our deep industry expertise to identify and support transformative therapeutic advancements that can improve patient outcomes. Our strategic investment approach focuses on fostering growth in the life sciences sector, ensuring that breakthrough therapies reach the market while enhancing the overall healthcare landscape. Through our commitment to innovation and excellence, Pivotal Life Sciences aims to be a catalyst for change in the medical field.
Investment Thesis
Pivotal Life Sciences is a global healthcare investment firm that supports companies developing high impact therapeutics to address major unmet medical needs. Their strategy is to invest in companies at all stages, with a primary focus on high impact therapeutics—solutions that address growing unmet medical needs and have nearcurative or transformative disease management potential. Pivotal Life Sciences aims to partner with scientists and entrepreneurs to support company building and derisking value inflection points.